PNEUMOCOCCAL INFECTION
Clinical trials for PNEUMOCOCCAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine targets more strains of dangerous pneumonia
⭐️ VACCINE ⭐️ CompletedThis study tested a new pneumonia vaccine called V116 in adults aged 18-64 who have a higher risk of getting sick from pneumococcal bacteria, such as those with diabetes, heart, lung, or kidney disease. Researchers compared V116 to a combination of two existing vaccines to see if…
Matched conditions: PNEUMOCOCCAL INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:11 UTC
-
New vaccine tested to better protect vulnerable kids from serious infections
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called V116 to see if it is safe and creates a strong immune response in children and teenagers who are at higher risk for pneumococcal disease. It involved 882 participants aged 2 to 17 who had already received their routine childhood pneumococcal…
Matched conditions: PNEUMOCOCCAL INFECTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:28 UTC